Why the study?
Does the formation of anti-HLA antibodies reduce survival in heart allograft recipients?
Does the formation of anti-HLA antibodies reduce survival in heart allograft recipients?
The formation of anti-HLA antibodies in heart transplant recipients is associated with significantly lower 4-year survival, suggesting a key role in chronic rejection.
Answers are grounded in this paper and cite their sources.
Anti-HLA antibody formation was associated with lower survival after heart transplant; hypothesis-generating and requires prospective validation before guiding care.
The major threat to long-term survival of heart allograft recipients is the development of graft atherosclerosis, which seems to be a manifestation of chronic rejection. To assess the role of anti-HLA antibodies in heart allograft rejection we studied 107 patients and compared the survival of recipients who formed anti-HLA antibodies with the survival of recipients who developed no antibodies. At 4 years the actuarial survival was 90% in the nonproducer group and 38% in antibody-producers (P = 0.038). We further explored the possibility that HLA antigens from the injured graft are released into the circulation and can be found in the serum either free or complexed with anti-HLA antibodies. This hypothesis was confirmed by the finding that the frequency of sera containing soluble HLA antigens from the graft or immune complexes of HLA alloantigens with anti-HLA antibodies was significantly higher in patients who rejected compared with patients with successful heart allografts (P less than 0.05). Following depletion of soluble HLA antigens, anti-HLA antibodies became detectable in 53% and 74% sera obtained during the first and second year posttransplantation, respectively, from patients undergoing chronic rejection. Long-term survivors showed a significantly lower (P less than 0.001) frequency of anti-HLA antibodies in sera depleted of HLA antigens. Lastly, studies of anti-anti-HLA-A2 and A3 antibodies in recipient sera suggest that quiescence is maintained by antiidiotypic antibodies.
No takes yet. Share an insight, caveat, or question.
Suciu‐Foca et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: